# A Study of the Effect of Multiple Doses of Rifampin on the Single Dose Pharmacokinetics of RO5424802

> **NCT01940510** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 24 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** RO5424802
- **DRUG:** rifampin

## Key facts

- **NCT ID:** NCT01940510
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2016-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01940510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01940510, "A Study of the Effect of Multiple Doses of Rifampin on the Single Dose Pharmacokinetics of RO5424802". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01940510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*